Medartis Holding AG
MDRSF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.43B
Close$
$71.04
38.2% downside
Current Fair Value
38.2% downsideOvervalued by 38.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.43 Billion |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0.67 |
| Beta | 1.17 |
| Outstanding Shares | 12,436,900 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 68.67 |
|---|---|
| PEG | -15.15 |
| Price to Sales | 2.67 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$188.53 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 2, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$211.30 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Medartis Holding AG
1,337 employees
CEO: Matthias Schupp
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticat...